Companies that use Greenlight Guru

Source: Analysis of 100 job postings that mention Greenlight Guru

I noticed that Greenlight Guru buyers are primarily Quality Assurance Managers (14%) and Directors overseeing quality and regulatory functions (9% in leadership roles). These decision-makers are focused on achieving compliance with ISO 13485, FDA 21 CFR Part 820, EU MDR, and MDSAP regulations while scaling their operations. Their strategic priorities center on implementing robust quality management systems, preparing for audits, and ensuring end-to-end traceability from design controls through post-market surveillance.

The day-to-day users are overwhelmingly quality and regulatory practitioners, with QA/QC Analysts representing 17% of roles, followed by Regulatory Affairs Specialists (11%), Document Control Specialists (9%), and QMS Engineers (6%). These hands-on users leverage Greenlight Guru for document management, change control workflows, design history file maintenance, CAPA management, deviation tracking, and training coordination. They're managing the complete product lifecycle from design inputs and risk management through verification, validation, and commercial manufacturing.

The pain points reveal companies struggling with fragmented systems and manual processes. Multiple postings mention transitioning from legacy platforms or needing to "implement" and "maintain" electronic QMS systems, indicating they're moving away from paper-based or inadequate digital solutions. One company specifically noted the need for "semi-automation of design controls and DHF deliverables," while another emphasized building "a team of software design assurance" professionals. The recurring theme is achieving "compliance with all applicable regulations" while enabling "faster" product development and maintaining "full traceability and audit readiness."

Source: Analysis of tech stacks from 438 companies that use Greenlight Guru

I noticed that Greenlight Guru users are clearly operating in highly regulated industries, specifically medical device and life sciences companies. The extreme correlation with Mastercontrol, a quality management system for regulated industries, combined with Benchling's presence as a life sciences R&D platform, tells me these are companies navigating FDA compliance and complex regulatory requirements. This isn't your typical software company tech stack.

The pairing of Mastercontrol and Greenlight Guru makes perfect sense because medical device companies need multiple layers of quality and compliance management. Benchling's appearance suggests these companies are doing actual product development and research, not just manufacturing or distribution. The heavy use of Jira Service Desk indicates they're managing complex internal workflows and likely coordinating across multiple departments like quality assurance, regulatory affairs, and product development. PR Newswire showing up 43 times more frequently than normal tells me these companies are actively managing public communications, probably around product launches, clinical trials, or regulatory approvals where transparency and formal announcements matter.

The full stack reveals companies that are compliance-first and process-driven by necessity. The presence of Intune for device management shows they take security seriously, which makes sense given the sensitive nature of medical data and intellectual property. Yoast suggests they're investing in content marketing and SEO, likely educating buyers about complex medical technologies. These appear to be growth-stage companies that are sales-led and marketing-led rather than product-led. They need to build trust and credibility in regulated markets where buying cycles are long.

Source: Analysis of Linkedin bios of 438 companies that use Greenlight Guru

I noticed these companies are predominantly medical device and biotechnology firms creating physical healthcare products. They manufacture everything from surgical instruments and implantable devices to diagnostic equipment and therapeutic systems. Many develop novel solutions for specific clinical problems: breath testing for cannabis detection, bone regeneration materials, cardiac assist devices, wound care technologies, and specialized imaging systems. A significant portion serves niche or underserved markets, particularly in orthopedics, diagnostics, and surgical tools.

These are primarily early to mid-stage companies. The employee counts cluster heavily in the 2-50 range, with funding stages spanning seed rounds to Series A/B. Many have achieved some commercialization, noting FDA clearances or initial market presence, but they're not yet scaled enterprises. The language about "developing," "commercializing," and seeking partnerships suggests they're actively building market presence rather than defending established positions. Several mention clinical trials or validation studies underway, indicating they're still proving their technologies.